Press Release NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout Aug 10
Press Release NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma Aug 10
Press Release NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors Jul 27
Press Release NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition Jul 15